Compare EXEL & GIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | GIL |
|---|---|---|
| Founded | 1994 | 1946 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 10.4B |
| IPO Year | 2000 | 1999 |
| Metric | EXEL | GIL |
|---|---|---|
| Price | $43.63 | $54.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 7 |
| Target Price | $46.45 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.3M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.66 | $76.47 |
| Revenue Next Year | $13.39 | $4.88 |
| P/E Ratio | ★ $15.78 | $23.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.38 | $40.17 |
| 52 Week High | $48.74 | $73.70 |
| Indicator | EXEL | GIL |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 31.04 |
| Support Level | $40.42 | $54.03 |
| Resistance Level | $45.88 | $58.43 |
| Average True Range (ATR) | 0.95 | 1.54 |
| MACD | 0.33 | -0.02 |
| Stochastic Oscillator | 90.88 | 15.38 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. It is a leader in blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels, a business that has been greatly enhanced by the Hanesbrands acquisition. Gildan's brands include Hanes, Bali, Maidenform, Playtex, Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates 90% of its sales in the US in 2025.